Moteur de recherche d’entreprises européennes

Financement de l’UE (9 995 920 €) : Des cohortes européennes de patients et des écoles pour faire progresser la réponse aux épidémies Hor14/10/2021 Programme de recherche et d'innovation de l'UE « Horizon »

Texte

Des cohortes européennes de patients et des écoles pour faire progresser la réponse aux épidémies

The EuCARE project gathers a comprehensive multidisciplinary team of clinicians, virologists, epidemiologists, statisticians and top experts in artificial intelligence to unveil the impact of SARS-CoV-2 variants on key sectors of public health, as addressed by the call. The specific activities include: 1. The assessment of natural and artificial immunity to the different viral variants in health care workers with the aim of defining the cross-immunization patterns and the risk of vaccine escape, informing vaccination strategies for the general population; 2. The analysis of the clinical course and long-term follow-up of hospitalized COVID-19 patients to derive the role of different viral variants in the outcome of the infection, including post-acute sequelae of SARS-CoV-2 infection; 3. The definition of the best strategies to control the spread of different viral variants in schools, by comparing the outcome of diverse containment and prevention measures in relation to the prevalence and dynamics of the variants. To ensure a suitable representativeness of the different variants, vaccines and preventive measures, EuCARE has secured the appropriate cohorts from diverse geographic areas including European countries, Kenya, Mexico, Russia and Vietnam, and will consolidate or expand interactions with other cohorts. To deal with complex interactions among many variables, including large dimensional parameters, EuCARE harnesses the power of artificial intelligence to define the role of viral variants and inform clinical guidelines and prevention measures. In the longer-term, EuCARE is committed to maintain active cooperation beyond the duration of the project with a dedicated task in the project. The solid IT and ethics infrastructure and the harmonised research procedures will make the cohort and laboratory network rapidly available to tackle newly emerging infectious diseases, thus contributing to pandemic preparedness on a global scale.


Azienda Socio-Sanitaria Territoriale (Asst) Santi Paolo E Carlo 500 000 €
EBERHARD KARLS UNIVERSITAET TUEBINGEN 487 250 €
Euresist Network GEIE 2 719 500 €
HEINRICH-HEINE-UNIVERSITAET DUESSELDORF 399 950 €
IBM ISRAEL - SCIENCE AND TECHNOLOGY Ltd. 465 125 €
Imperial College of Science Technology and Medicine 450 000 €
Infectious Diseases, Aids AND Clinical Immunology Research Center 5 000,00 €
Istituto Europeo Di Oncologia Srl 549 975 €
Istituto Nazionale Per LE Malattie Infettive Lazzaro Spallanzani-Istituto Di Ricovero E Cura A Carattere Scientifico 70 000 €
Karolinska Institutet 764 687 €
KLINIKUM DER UNIVERSITAET ZU KOELN 600 000 €
Organizing Bureau OF European School Student Unions 56 750 €
Pomorski Uniwersytet Medyczny w Szczecinie 231 250 €
Unidade Local de Saude Lisboa Ocidental ΕΠΕ 371 875 €
Universidade Nova de Lisboa 563 875 €
Universita Degli Studi Di Roma TOR Vergata 436 875 €
Universita Degli Studi Di Siena 600 000 €
Universita Del Salento 286 500 €
University College London 112 933 €
VILNIAUS UNIVERSITETO LIGONINE SANTAROS KLINIKOS 324 375 €

https://cordis.europa.eu/project/id/101046016

Cette annonce se réfère à une date antérieure et ne reflète pas nécessairement l’état actuel.